Immunomodulation as therapy for fungal infection: Are we closer?

• Main Authors: Sam, Q.H., Yew, W.S., Seneviratne, C.J., Chang, M.W., Chai, L.Y.A.
• Other Authors: BIOCHEMISTRY
• Format: Review
• Published: Frontiers Media S.A. 2020
• Subjects: auranofin; colony stimulating factor 1; cytokine receptor agonist; deferasirox; ebselen; efungumab; gamma interferon; granulocyte colony stimulating factor; granulocyte macrophage colony stimulating factor; interleukin 12p40; interleukin 6; molgramostim; probiotic agent; recombinant gamma interferon; recombinant granulocyte macrophage colony stimulating factor; retinol; sargramostim; suppressor of cytokine signaling 3; tamoxifen; toll like receptor 9; toll like receptor agonist; tumor necrosis factor; vitamin D; adoptive T cell therapy; antifungal therapy; cell therapy; chimeric antigen receptor natural killer cell immunotherapy; chimeric antigen receptor T-cell immunotherapy; clinical trial (topic); cryptococcal meningitis; cryptococcosis; Cryptococcus neoformans; drug repositioning; granulocyte transfusion; human; immunomodulation; microbiome; nonhuman; phase 1 clinical trial (topic); phase 2 clinical trial (topic); Review; systemic mycosis; T lymphocyte
• Online Access: https://scholarbank.nus.edu.sg/handle/10635/174534
• Institution: National University of Singapore

10.3389/fmicb.2018.01612